FPH Announces New Chief Financial Officer

Fisher & Paykel Healthcare Announces New Chief Financial Officer Auckland, New Zealand, 23 October 2018 - Fisher & Paykel Healthcare Corporation Limited announced today that Lyndal York has been appointed Chief Financial Officer. Mrs York will join the company in March 2019, reporting to Chief Executive Officer, Lewis Gradon. Mrs York is currently CFO at ASX-listed Asaleo Care, based in Melbourne, Australia. In this role, she manages the core CFO financial roles, in addition to investor relations and information technology. Prior to her role at Asaleo Care, she held Head of Group Finance and Group Financial Controller roles at Cochlear over an 11-year period. She has also spent time in the US, as VP Corporate Accounting and Reporting at Edwards Lifesciences. "We are delighted to welcome Lyndal to the Fisher & Paykel Healthcare team," said Managing Director and CEO, Lewis Gradon. "Lyndal has strong international experience within the medical device industry, and as such, possesses a good understanding of its unique characteristics. We have a high performing and aspirational team in place and are very much looking forward to Lyndal joining us next year. I would also like to acknowledge Andrea Blackie, who has been performing the role of Acting Chief Financial Officer since 1 June 2018." Mrs York replaces long-time CFO Tony Barclay, who retired from the company in May 2018. Andrea Blackie will continue in her role as Acting CFO until Mrs York joins the company in March 2019, at which point she will resume her role of General Manager - Finance. Mrs York said, "I am looking forward to joining the Fisher & Paykel Healthcare team. The company is well respected and highly successful on the global stage and I am excited to help it continue to build its reputation for sustainable growth and innovation." About Fisher & Paykel Healthcare Fisher & Paykel Healthcare is a leading designer, manufacturer and marketer of products and systems for use in respiratory care, acute care, surgery and the treatment of obstructive sleep apnea. The company's products are sold in over 120 countries worldwide. For more information about the company, visit our website www.fphcare.com. Ends A photograph of Mrs York is available. For a copy, please email rachel.reynolds@fphcare.co.nz Biography o 2017 - present: Chief Financial Officer, Asaleo Care o 2006 - 2017: Head of Group Finance, Group Financial Controller, Cochlear Limited o 2004 - 2005: VP Corporate Accounting and Reporting, Edwards Lifesciences o Member, Chartered Accountants Australia and New Zealand o Graduate of the Australian Insitute of Company Directors o Bachelor of Economics, Macquarie University o Executive MBA, Pepperdine University Contact: Investors: Marcus Driller General Manager Corporate marcus.driller@fphcare.co.nz +64 (0) 27 578 9663 Media: Rachel Reynolds Senior Communications Manager rachel.reynolds@fphcare.co.nz +64 (0) 21 713 911 End CA:00325653 For:FPH Type:GENERAL Time:2018-10-23 10:38:42